Board summary
Key figures
30,348
Registered population
57.8% aged 18–64
26.0%
Aged 65+
ICB 20.0% · England 17.9%
1.9%
Ethnic minority (non-White)
0.8% Asian
0.0%
In IMD quintile 1
ICB 30.6% · England 21.0%
0
Core20 residents (est.)
Resident basis; registered basis 0 · see page 3
5,539
Hypertension register
+7.43% in 3 yrs · England +5.60%
293
SMI register
13.3% of Westmorland and Furness (LAD)'s
560
COPD register
Reviews -5.12% in 3 yrs
Forecast to 2030
6,509
Hypertension patients, 2030
+970 on today
59.8%
QRISK ≥20% on statins, 2030
+2.04pp over 3 yrs
6.5%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
COPD register and review rates contracted.
COPD prevalence fell 6.2% over three years (England +2.6%) and annual reviews fell 5.1% (England +2.8%), with a +15 to +52 modelled gap.
High-risk lipid therapy and SMI checks trail.
Only 55.5% of QRISK ≥ 20% patients receive lipid therapy (England 63.6%), while SMI blood pressure (76.3%) and BMI (74.1%) checks trail England.
Heart failure reviews and BP control grew.
Heart failure reviews rose 19.9% over three years to 83.5% (England 78.5%), and hypertension treatment to target rose 7.1% to 70.9% (England 70.3%).
Population, age and ethnicity
Patients aged 65+ make up 26.0% of the list, well above England's 17.9%
Mid Furness PCN serves 30,348 registered patients across four practices. Patients aged 65+ represent 26.0% of the list (7,902 patients), above Westmorland and Furness (25.9%), the ICB (20.0%) and England (17.9%). Children aged 0-17 comprise 16.2% (4,909 patients; LAD 15.8%, ICB 19.6%, England 19.6%), and working-age adults 57.8% (17,537 patients; LAD 58.4%, ICB 60.4%, England 62.7%). Census usual resident data shows 98.1% White and a 1.9% ethnic minority share, though this reflects local residents rather than registered patients. Projected population growth to 2030 is 1.2% (LAD 1.7%, ICB 1.7%, England 2.3%), under an unverified methodology.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Westmorland and Furness (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Westmorland and Furness LA) | 1,591 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 83.1% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 61.4% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Westmorland and Furness LA) | 736 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Westmorland and Furness LA) | 10.5 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Zero registered patients live in Core20 areas, but severe mental illness checks lag England
The PCN records 0.0% of registered patients (0 patients) in the Core20 cohort, compared with 9.2% in Westmorland and Furness, 30.6% in the ICB, and 21.0% in England, with an average IMD decile of 6.3 (England 5.5). While area deprivation is low, routine monitoring for 293 severe mental illness patients trails national rates: blood pressure checks reach 76.3% (England 83.4%), BMI 74.1% (England 82.1%), and alcohol recording 64.2% (England 81.8%). Lower check completion rates among patients with severe mental illness indicate an opportunity to review routine annual monitoring pathways.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
293
SMI register
0.96% recorded prevalence
133
Learning disability register
0.44% recorded prevalence
8
Care homes, 289 beds
In the PCN catchment
Mid Furness records 293 patients on the severe mental illness register (1.0%, England 1.0%) and 133 on the learning disability register (0.4%, England 0.6%). The catchment includes 8 care homes (289 beds), while Westmorland and Furness recorded 14 rough sleepers in autumn 2025. Illustrative register gap modelling suggests 35 to 45 learning disability patients against borough and England benchmarks, though this does not indicate confirmed under-detection.
Severe mental illness: physical health checks
Recorded SMI prevalence is 1.0% (293 patients). Physical checks trail England: 76.3% had blood pressure checked (England 83.4%, dropping to 62.1% at Ulverston Community Health Centre) and 74.1% had BMI recorded (England 82.1%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,539
Hypertension register
+7.43%
Register growth, 3 yrs
Westmorland and Furness (LAD) +6.93% · England +5.60%
+4.42pp
BP control, under 80
≤140/90 · +4.11pp aged 80+
+970
More patients by 2030
Forecast 6,509 (21.00%)
Hypertension case-finding and control
Recorded hypertension prevalence is 18.2% (5,539 patients), matching Westmorland and Furness (18.2%) and exceeding the ICB (17.2%) and England (15.2%), though crude rates are not age-adjusted. Blood pressure monitoring is 90.1% (England 90.0%). Blood pressure control for patients under 80 is 66.9%, trailing England (67.8%) and the borough (68.0%), and dropping to 65.8% at Ulverston Medical Practice. Lower control than England indicates an opportunity to expand home monitoring titration and review at lagging practices.
Lipids and statins
Primary prevention lipid therapy reaches 55.5% of patients with QRISK ≥ 20% and 68.2% with diabetes aged 40+ without CVD, trailing England (63.6% and 73.2%). Lower reach than England suggests an opportunity to audit lipid initiation across both cohorts.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 48,594 | £2.20 | £1.64 | £1.86 | £106,907 |
| Cardiovascular (all), 2025 | 71,551 | £5.38 | £3.38 | £3.33 | £384,944 |
For Lipid-regulating drugs 2026, the PCN prescribed 48,594 items at £2.20 per item, above England (£1.86) and the ICB (£1.64), spending £27,213 more than at ICB unit cost. Higher unit cost than ICB benchmarks highlights an opportunity to review formulary selection alongside expanding treatment reach.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+1.57%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+0.81%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 1.8% (560 patients; England 1.9%, LAD 2.0%), falling 6.2% over three years (England +2.6%). Annual reviews reached 77.5% (England 76.4%), but fell 5.1% over three years (England +2.8%). A benchmark model suggests a register gap of +15 to +52 patients. Asthma prevalence is 8.2% (2,392 patients; England 6.6%) and reviews reached 74.2% (England 65.7%), leaving about 620 unreviewed. Contraction could reflect list validation or under-detection, which clinical audit would test.
Cancer register and children's immunisation
Cancer prevalence is 5.1% (1,562 patients), above England (3.8%). Childhood immunisations exceed benchmarks: 6-in-1 coverage at 12 months is 94.9% (59 children), 0.1 pp below the 95.0% target, reaching 98.1% at 24 months. At age 5, MMR first-dose coverage is 100.0% but second-dose uptake drops 2.3 pp to 97.7%, indicating an opportunity to eliminate pre-school second-dose drop-off.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2, below England (55.3%) and 22.6 pp below the 75.0% national ambition. Reaching that ambition requires about 2,010 extra early-stage diagnoses annually across the ICB. Known-stage cancers comprised 74.6% of 11,883 registrations, exceeding England (67.0%). Early presentation varied: breast was 86.0%, lung was 31.1% and oesophagus was 11.1%. These figures reflect ICB pathways rather than PCN performance. Local practices can support earlier detection by reviewing safety-netting protocols.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026 (provisional), University Hospitals of Morecambe Bay NHS Foundation Trust achieved 72.4% on the cancer 62-day referral to treatment standard, 12.6 pp below the 85.0% standard. This compared with 73.6% for NHS Lancashire and South Cumbria Integrated Care Board, 71.2% in England, 70.9% at North Cumbria Integrated Care NHS Foundation Trust, and 67.5% at Blackpool Teaching Hospitals NHS Foundation Trust. The trust met the 75.0% 28-day faster diagnosis standard at 78.4% (ICB 78.4%, England 79.3%). For diagnostics, colonoscopy 6-week waits stood at 0.6% (England 30.8%) and CT at 13.8% (England 9.9%).
| Pathways within standard (%) | of Morecambe Bay | Blackpool | North Cumbria Integrated Care | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 78.39 | 71.38 | 78.33 | 78.39 | 79.32 |
| 31-day treatment (96%) | 95.22 | 97.96 | 93.09 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 72.35 | 67.48 | 70.90 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | of Morecambe Bay | Blackpool | North Cumbria Integrated Care | England |
|---|---|---|---|---|
| MRI | 4.04 | 21.80 | 9.59 | 21.40 |
| CT | 13.76 | 16.49 | 0.63 | 9.92 |
| Echocardiography | 10.55 | 7.57 | 1.33 | 28.48 |
| Colonoscopy | 0.60 | 13.08 | 5.50 | 30.83 |
| Gastroscopy | 1.45 | 12.47 | 10.90 | 29.02 |
| All 15 DM01 tests | 10.44 | 26.54 | 16.60 | 23.14 |
| Community services activity | Westmorland and Furness residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 53,485 | 193,720 |
| Referrals | 6,470 | 29,855 |
| Patients with a contact | 13,445 | 65,335 |
Community services (residents of Westmorland and Furness), Jun 2026 (provisional). In Jun 2026 (provisional), community service activity for Westmorland and Furness residents recorded 53,485 total contacts, with 36,330 involving adults aged 65 and over, representing 67.9% of all contacts. These data reflect activity across the local authority rather than PCN-registered patients, showing substantial older-age community caseloads across the wider care system.
Practice variation and patient experience
Practice variation and patient experience
In 2025/26, overall QOF achievement exceeds England (92.5%) across all practices, from 96.3% at Ulverston Community Health Centre to 97.9% at Duddon Valley Medical Practice. Vaccination and immunisation achievement varies by 24.8 pp, from 68.6% at Ulverston Community Health Centre to 93.5% at Ulverston Medical Practice, while all exceed England (55.2%).
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Ulverston | 107 | 0.0 | 74.6% | 76.8% | 89.2% |
| Duddon Valley | 115 | 0.0 | 79.3% | 69.2% | 84.6% |
| Ulverston Medical | 111 | 0.0 | 65.7% | 73.6% | 83.4% |
| Dalton Surgery | 117 | 0.0 | 36.9% | 82.9% | 81.7% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Eleven of 25 tracked measures trail England over three years, led by register contractions
Between 2023 and 2025, 11 of 25 tracked measures trailed England's three-year change. Relative contractions led the lags: the COPD register fell 6.2% (England +2.6%) and the learning disability register fell 2.9% (England +5.4%, Westmorland and Furness +0.6%). Conversely, cardiovascular delivery showed notable strength: annual heart failure reviews rose 19.9% (England +8.7%) to reach 83.5%, while patients with hypertension treated to target rose 7.1% (England +3.6%) to 70.9%. Register contractions could reflect list validation or under-detection, which local clinical audit would test.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
COPD register
Learning disability register
COPD reviews
Breast screening (53-70)
Alcohol record (psychosis)
Heart failure reviews
BP control, under 80
Hypertension treated to target
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Westmorland and Furness (LAD) | Asset | PCN | Westmorland and Furness (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 8 (289 beds) | n/a | Schools (catchment) | 34 | n/a |
| Children's centres | 2 | 12 | Places of worship | 37 | 316 |
| Libraries | 2 | 14 | Food banks (VCS) | n/a | 2 |
| Day centres (VCS) | n/a | 2 | Children and young people (VCS) | n/a | 3 |
| Carers support groups (VCS) | n/a | 2 | Primary schools (LA maintained) | 11 | 82 |
| Primary academies | 5 | 27 | Special schools | 1 | 4 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Validate COPD register and reviews
COPD prevalence is 1.8% (560 patients; LAD 2.0%, England 1.9%), falling 6.2% over 2023 to 2025 (England +2.6%), with a modelled gap of +15 to +52 patients. For discussion: audit patients on repeat respiratory prescribing without a COPD code, combine annual review recall, and raise spirometry access with system partners. Moderate effort to run.
Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.
Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.
Option 2
Standardise SMI physical health recall
For 293 severe mental illness patients, blood pressure checks reach 76.3% (England 83.4%, Ulverston Community Health Centre 62.1%), BMI 74.1% (England 82.1%) and alcohol recording 64.2% (England 81.8%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Review lipid initiation and BP titration
Lipid therapy reaches 55.5% for QRISK ≥ 20% (England 63.6%). Under-80 hypertension BP control is 66.9% (England 67.8%, Ulverston Medical Practice 65.8%). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Mental health physical check outreach (p3) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Severe mental illness health checks (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension blood pressure control review (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school second dose recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cancer safety netting audit (p7) | Cancers diagnosed at stage 1 or 2 (All cancer sites) | — | ICB |
| Option 1 · Validate COPD register and reviews (p12) | COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 months | Core20PLUS5 approach · Tobacco and Vapes Bill | PCN |
| Option 2 · Standardise SMI physical health recall (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
| Option 3 · Review lipid initiation and BP titration (p12) | Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapy | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
